Literature DB >> 16301995

Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.

C Britschgi1, M Rizzi, T J Grob, M P Tschan, B Hügli, V A Reddy, A-C Andres, B E Torbett, A Tobler, M F Fey.   

Abstract

The tumor suppressor gene hypermethylated in cancer 1 (HIC1), located on human chromosome 17p13.3, is frequently silenced in cancer by epigenetic mechanisms. Hypermethylated in cancer 1 belongs to the bric à brac/poxviruses and zinc-finger family of transcription factors and acts by repressing target gene expression. It has been shown that enforced p53 expression leads to increased HIC1 mRNA, and recent data suggest that p53 and Hic1 cooperate in tumorigenesis. In order to elucidate the regulation of HIC1 expression, we have analysed the HIC1 promoter region for p53-dependent induction of gene expression. Using progressively truncated luciferase reporter gene constructs, we have identified a p53-responsive element (PRE) 500 bp upstream of the TATA-box containing promoter P0 of HIC1, which is sequence specifically bound by p53 in vitro as assessed by electrophoretic mobility shift assays. We demonstrate that this HIC1 p53-responsive element (HIC1.PRE) is necessary and sufficient to mediate induction of transcription by p53. This result is supported by the observation that abolishing endogenous wild-type p53 function prevents HIC1 mRNA induction in response to UV-induced DNA damage. Other members of the p53 family, notably TAp73beta and DeltaNp63alpha, can also act through this HIC1.PRE to induce transcription of HIC1, and finally, hypermethylation of the HIC1 promoter attenuates inducibility by p53.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16301995     DOI: 10.1038/sj.onc.1209240

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.

Authors:  Capucine Van Rechem; Gaylor Boulay; Sébastien Pinte; Nicolas Stankovic-Valentin; Cateline Guérardel; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 2.  HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.

Authors:  Capucine Fleuriel; Majid Touka; Gaylor Boulay; Cateline Guérardel; Brian R Rood; Dominique Leprince
Journal:  Int J Biochem Cell Biol       Date:  2008-08-03       Impact factor: 5.085

3.  Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.

Authors:  Mario P Tschan; Elena A Federzoni; Aladin Haimovici; Christian Britschgi; Bettina A Moser; Jing Jin; Venkateshwar A Reddy; Dennis A Sheeter; Kimberlee M Fischer; Peiqing Sun; Bruce E Torbett
Journal:  Biochim Biophys Acta       Date:  2015-07-15

4.  DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.

Authors:  Vanessa Dehennaut; Ingrid Loison; Marion Dubuissez; Joe Nassour; Corinne Abbadie; Dominique Leprince
Journal:  J Biol Chem       Date:  2013-02-15       Impact factor: 5.157

5.  Lipid droplet and early autophagosomal membrane targeting of Atg2A and Atg14L in human tumor cells.

Authors:  Simon G Pfisterer; Daniela Bakula; Tancred Frickey; Alice Cezanne; Daniel Brigger; Mario P Tschan; Horst Robenek; Tassula Proikas-Cezanne
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

6.  An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.

Authors:  Nicolas Stankovic-Valentin; Sophie Deltour; Jacob Seeler; Sébastien Pinte; Gérard Vergoten; Cateline Guérardel; Anne Dejean; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

7.  Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.

Authors:  Ruo-Chia Tseng; Chin-Chu Lee; Han-Shui Hsu; Ching Tzao; Yi-Ching Wang
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

8.  HIC1 regulates tumor cell responses to endocrine therapies.

Authors:  Baohua Zhang; Douglas V Faller; Sheng Wang
Journal:  Mol Endocrinol       Date:  2009-10-09

9.  Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control.

Authors:  B Zhang; K J Chambers; D Leprince; D V Faller; S Wang
Journal:  Oncogene       Date:  2008-11-17       Impact factor: 9.867

Review 10.  Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.

Authors:  Brian R Rood; Dominique Leprince
Journal:  Expert Opin Ther Targets       Date:  2013-04-09       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.